The Democrats held their national convention last week, and this week the Republicans follow suit. To help see the forest for the trees for these two weeks, here’s a quick summary of where both President Donald Trump and Joe Biden stand on healthcare policy.
We’ll start off easy: the Patient Protection and Affordable Care Act (PPACA) figures prominently in the approaches to healthcare for both campaigns. If you look at the White House’s official page on healthcare and Biden’s formal campaign platform, the PPACA is mentioned in the first sentence of both.
The Trump Administration has been and is trying to overturn the PPACA, and in fact, the U.S. Supreme Court announced last week that it will hear the administration’s challenge to the law on Nov. 10, 2020 – that is, a week after the election. In the meantime, President Trump has promised he will soon release his own healthcare plan. One of the Republican Party’s primary issues with the PPACA, including its Medicaid expansion, was that it was federally driven. Republicans in general felt that the states should have more control over healthcare policy. President Trump’s expected healthcare plan will likely reflect this state-centric approach.
Biden, as part of the Obama Administration that passed the law, would like to see the PPACA strengthened and broadened.
The key element in the Biden healthcare platform is a public health plan option, built on the PPACA, that would available to all, even if your employer offers healthcare benefits. The plan would be modeled after Medicare in how it negotiates lower prices from providers, but Biden has made it clear that his public option is not “Medicare for all:” it is not a single-payer system that would replace commercial insurance.
One of the pillars of the PPACA is protection for people with preexisting conditions. President Trump has said that he supports that element of the PPACA, and in fact, he has signaled that he may sign an executive order on preexisting conditions in the coming days.
The two candidates have other common healthcare goals. Trump’s and Biden’s respective approaches to lowering the cost of prescription drugs are very similar. Both also support a prohibition on surprise balance billing of patients, though neither give details on how surprise out-of-network provider reimbursement should be managed. Both campaigns have also put forward plans to battle the opioid crisis, although the strategies have significant differences.
Enough kumbaya: other differences include Biden’s goal of addressing anti-trust issues by looking at the market concentration in healthcare systems; no specific details on that yet. Trump, for his part, has been very focused on healthcare cost transparency. Cost transparency has not figured prominently in Biden’s platform.
Lastly, the two differ on their approach to the current pandemic. According to his platform, Biden envisions greater national control over the response, including developing more prescriptive guidelines governing public and private businesses reopening.
President Trump has spoken about the successes his administration has had in fighting the pandemic and its economic impact. In contrast to Biden’s platform, Trump has tended to leave more control to the states to decide how to respond and manage government reaction to the pandemic.
In this pandemic, discussions about healthcare take place almost daily in our homes; healthcare issues and policies saturate the media. We all know more about vaccine development and contact tracing than we ever cared to know. In this environment, over the coming weeks, the two candidates will have to persuade a well-informed electorate of their respective healthcare approaches.
Programming Note: Matthew Albright is a permanent panelist on Monitor Mondays. Listen to his legislative update sponsored by Zelis, Mondays at 10 a.m. EST.
As expected, the federal shutdown began early Wednesday morning. What’s unknown is how long it will continue. Neither congressional Republicans nor Democrats appear to be
The One Big Beautiful Bill Act, signed into law on July 4, 2025, includes sweeping changes to Medicaid including work requirements, cost-sharing, eligibility verification, and federal
Please log in to your account to comment on this article.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
